Efficacy and safety of UCB-derived or autologous CIK cells combined with interferon therapy in patients with chronic hepatitis B

ObjectiveTo investigate the efficacy and safety of umbilical cord blood (UCB)-derived or autologous cytokine-induced killer (CIK) cells combined with interferon therapy in patients with chronic hepatitis B (CHB). MethodsThirty CHB patients hospitalized in the Department of Infectious Diseases from O...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yazar: LIU Bo
Materyal Türü: Artigo
Dil:Chinês
Baskı/Yayın Bilgisi: Editorial Department of Journal of Clinical Hepatology 2014-09-01
Seri Bilgileri:Linchuang Gandanbing Zazhi
Konular:
hepatitis B
chronic; killer cells; interferon type Ⅱ
Online Erişim:http://www.lcgdbzz.org/qk_content.asp?id=6003&ClassID=86133151
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller